(Q30354769)

20 June 2017

title

Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A/H1N1 (H1N1pdm09) vaccine. (English)

1 reference

20 June 2017

0 references

1 reference

1 reference

2

Gaston De Serres

1 reference

20 June 2017

4

Danuta M Skowronski

1 reference

20 June 2017

Isabelle Rouleau

1

1 reference

20 June 2017

Jean Philippe Drolet

3

1 reference

20 June 2017

Manale Ouakki

5

1 reference

20 June 2017

Eveline Toth

6

1 reference

20 June 2017

Monique Landry

7

1 reference

20 June 2017

Suzanne Ménard

8

1 reference

20 June 2017

Rémi Gagnon

9

1 reference

20 June 2017

language of work or name

English

0 references

publication date

19 October 2013

1 reference

20 June 2017

1 reference

20 June 2017

volume

31

1 reference

20 June 2017

issue

50

1 reference

20 June 2017

page(s)

5989-5996

1 reference

Anaphylactic shock after insect-sting challenge in 138 persons with a previous insect-sting reaction.

20 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.033

Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.033

Analysis of food-allergic and anaphylactic events in the National Electronic Injury Surveillance System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.033

Diagnostic utility of two case definitions for anaphylaxis: a comparison using a retrospective case notes analysis in the UK

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.033

Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.033

Risk of Anaphylaxis After Vaccination of Children and Adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.033

Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.033

Use of epinephrine in the treatment of anaphylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.033

Gender difference, sex hormones, and immediate type hypersensitivity reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.033

Type 1/Type 2 immunity in infectious diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.033

Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.033

Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.033

Monitoring adverse events of the vaccination campaign against influenza A (H1N1) in the Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.033

Spontaneous reporting of adverse events following immunisation against pandemic influenza in Denmark November 2009-March 2010.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.033

Anaphylaxis following H1N1 pandemic vaccines: safety data in perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.033

Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.033

Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.033

10.1016/J.VACCINE.2013.10.033

7 January 2021

Identifiers

DOI

1 reference

20 June 2017

1 reference